— Know what they know.
Not Investment Advice

Financial News

Sentiment 33.5 5412 articles 2813 bullish 1207 bearish Full Index →
📰

Portnoy Law Firm Announces Class Action on Behalf of Inovio Pharmaceuticals, Inc. Investors

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

Portnoy Law Firm Announces Class Action on Behalf of Mereo BioPharma Group plc Investors

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
Should You Continue to Hold OMCL Stock in Your Portfolio?

Should You Continue to Hold OMCL Stock in Your Portfolio?

Omnicell's autonomous pharmacy push and SaaS growth show promise, but rising costs and weak hospital spending cloud its near-term outlook.
Should You Continue to Hold OMCL Stock in Your Portfolio?

Should You Continue to Hold OMCL Stock in Your Portfolio?

Omnicell's autonomous pharmacy push and SaaS growth show promise, but rising costs and weak hospital spending cloud its near-term outlook.
Should You Continue to Hold OMCL Stock in Your Portfolio?

Should You Continue to Hold OMCL Stock in Your Portfolio?

Omnicell's autonomous pharmacy push and SaaS growth show promise, but rising costs and weak hospital spending cloud its near-term outlook.
Should You Continue to Hold OMCL Stock in Your Portfolio?

Should You Continue to Hold OMCL Stock in Your Portfolio?

Omnicell's autonomous pharmacy push and SaaS growth show promise, but rising costs and weak hospital spending cloud its near-term outlook.
📰

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aquestive Therapeutics, Inc. (AQST)

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on...
📰

Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates

Sanara MedTech (SMTI) delivered earnings and revenue surprises of -63.64% and +0.53%, respectively, for the quarter ended December 2025. Do the...
📰

Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates

Sanara MedTech (SMTI) delivered earnings and revenue surprises of -63.64% and +0.53%, respectively, for the quarter ended December 2025. Do the...
📰

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Zynex, Inc. (ZYXIQ)

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on...
📰

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against uniQure N.V.

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on...
📰

Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue Estimates

Adherex Technologies (FENC) delivered earnings and revenue surprises of -540.00% and -7.94%, respectively, for the quarter ended December 2025. Do...
📰

Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue Estimates

Adherex Technologies (FENC) delivered earnings and revenue surprises of -540.00% and -7.94%, respectively, for the quarter ended December 2025. Do...
Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tu

Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Tuesday. Shares of Hesai Group – ADR (NASDAQ:HSAI) fell...
Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tu

Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Tuesday. Shares of Hesai Group – ADR (NASDAQ:HSAI) fell...
Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tu

Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Tuesday. Shares of Hesai Group – ADR (NASDAQ:HSAI) fell...
Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tu

Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Tuesday. Shares of Hesai Group – ADR (NASDAQ:HSAI) fell...
OpenAI Warns Investors Of 'Microsoft Dependency' Hazard

OpenAI Warns Investors Of 'Microsoft Dependency' Hazard

OpenAI warned investors that its heavy dependence on Microsoft Corp. (NASDAQ:MSFT) for "a substantial portion of our financing and compute" could...
📰

OpenAI Warns Investors Of 'Microsoft Dependency' Hazard

OpenAI warned investors that its heavy dependence on Microsoft Corp. (NASDAQ:MSFT) for "a substantial portion of our financing and compute" could...
📰
Memory Chip Shortage Clouds Foxconn Smartphone Unit's Profit

Memory Chip Shortage Clouds Foxconn Smartphone Unit's Profit Outlook

The smartphone arm of electronics giant Foxconn benefited from increased shipments to a key customer last year, as it reported an annual net profit...
Broadcom Warns Taiwan Semiconductor Capacity Is Maxed Out

Broadcom Warns Taiwan Semiconductor Capacity Is Maxed Out

On Tuesday, Broadcom Inc. (NASDAQ:AVGO) signaled growing strain in the AI supply chain, warning that limited capacity at Taiwan Semiconductor...
Scott Bessent Rules Out Tax Hikes To Fund Iran War As Costs

Scott Bessent Rules Out Tax Hikes To Fund Iran War As Costs Climb: 'Why Would We...'

Treasury Secretary Scott Bessent dismissed raising taxes to fund the U.S. military campaign in Iran as "not at all" under consideration, calling the...
📰

FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc.

NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Fulgent Genetics Inc....
📰

Globus Medical Announces Board Departure

AUDUBON, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced...
📰

If You Only Own Tech Stocks, Jim Cramer Has a Blunt Warning for You in 2026

CNBC commentator Jim Cramer sees value in the artificial intelligence (AI) realm beyond the technology sector.
📰

Context Therapeutics GAAP EPS of -$0.38

📰

Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Voluntary pause of the Phase 3 HERO and OLE trials evaluating ARD-101 for the treatment of hyperphagia in individuals with Prader-Willi Syndrome,...
📰

Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

Pfizer Stock Is Doing Something It Hasn't Done Since 2022

Up until recently, the stock has been a chronic underperformer.
📰

Shareholders that lost money on Picard Medical, Inc.(PMI) should contact Levi & Korsinsky about pending Class Action - PMI

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>NEW...
📰

Levi & Korsinsky, LLP: Rare Stock Loss Quantifies Investor Damages Following Phase III Study Failure Disclosure

NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP reminds purchasers of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)...
📰

NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealed Trial Protocol Violations: Levi & Korsinsky

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>NEW...
📰

Levi & Korsinsky, LLP: Fraud-on-the-Market Doctrine Underpins Mereo BioPharma Securities Class Action

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>NEW...
« Prev 1 9 10 11 12 13 23 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms